ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 208652 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 208652; 2) Community: the network communities that were significantly associated with the response to NSC 208652; 3) Molecule: the relationships between components within communities and NSC 208652; 4) MDR: the compounds that were significantly associated with the NSC 208652.

NSC Compound Enrichment Correlation
NSC 88915 Null 0.00770426557728506 0.27278241
NSC 129794 Ethanesulfonic acid, compd. with 2-chloro-5-[4-[m-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) 0.00803384002766641 0.41549992
NSC 13151 Null 0.00803384002766641 0.12227805
NSC 254665 JUSTICIDIN B 0.00803384002766641 0.13637049
NSC 267713 Digitoxigenin glycoside 0.00803384002766641 0.23445552
NSC 300289 Pinafide 0.00803384002766641 0.21814581
NSC 303861 L-Cysteine analog 0.00803384002766641 0.31335574
NSC 3077 s-Triazine, 4,6-diamino-1-(3,4-dichlorophenyl)-1,2-dihydro-2,2-dimethyl-, monohydrochloride (8CI) 0.00803384002766641 0.70470721
NSC 33570 Null 0.00803384002766641 0.34339606
NSC 363813 Platinum, tetrachloro(1,2-cyclohexanediamine-N,N')-, [OC-6-22-(1S-trans)]- 0.00803384002766641 0.28348446
Total:117  Current:40    [First] [Prev] [Next] [Last]